4//SEC Filing
Shaked Yoav 4
Accession 0001104659-23-057159
CIK 0001533998other
Filed
May 7, 8:00 PM ET
Accepted
May 8, 4:12 PM ET
Size
7.9 KB
Accession
0001104659-23-057159
Insider Transaction Report
Form 4
Shaked Yoav
Director
Transactions
- Purchase
Series B-2 Preferred Stock
2023-05-04$1000.00/sh+40$40,000→ 40 totalExercise: $3.37From: 2023-05-04Exp: 2026-05-04→ Common Stock
Holdings
- 166,193
Common Stock
- 1,667(indirect: By Spouse)
Common Stock
Footnotes (3)
- [F1]The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
- [F2]The Series B Preferred Stock will automatically convert into shares of common stock, subject to certain beneficial ownership limitations, including a non-waivable 19.99% ownership blocker, on the 15-month anniversary of the issuance date.
- [F3]The Series B Preferred Stock initially converts into shares of common stock at a conversion price of $3.37. In addition, the holders of Series B Preferred Stock will also be entitled dividends payable as follows: (i) a number of shares of Common Stock equal to five percent (5.0%) of the number of shares of Common Stock issuable upon conversion of the Series B Preferred Stock then held by such holder for each full quarter anniversary of holding for a total of four (4) quarters from the closing date, and (ii) a number of shares of common stock equal to ten percent (10%) of the number of shares of common stock issuable upon conversion of the Series B Preferred Stock then held by such holder on the fifth full quarter from the closing date.
Documents
Issuer
DarioHealth Corp.
CIK 0001533998
Entity typeother
Related Parties
1- filerCIK 0001744499
Filing Metadata
- Form type
- 4
- Filed
- May 7, 8:00 PM ET
- Accepted
- May 8, 4:12 PM ET
- Size
- 7.9 KB